Imagin Medical Inc. (IMEXF)
- Previous Close
0.0059 - Open
0.0059 - Bid --
- Ask --
- Day's Range
0.0059 - 0.0059 - 52 Week Range
0.0059 - 0.1240 - Volume
1,050 - Avg. Volume
577 - Market Cap (intraday)
118,905 - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. It has a license agreement with Lawrence Livermore National Security, LLC to develop and commercialize the i/Blue Imaging System. The company was founded in 1986 and is headquartered in Vancouver, Canada.
imaginmedical.comRelated News
Performance Overview: IMEXF
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMEXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMEXF
Valuation Measures
Market Cap
118.90k
Enterprise Value
10.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-13.45
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-191.49%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.32M
Diluted EPS (ttm)
-0.2000
Balance Sheet and Cash Flow
Total Cash (mrq)
22.17k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-241.69k
Company Insights: IMEXF
IMEXF does not have Company Insights